Opinion|Videos|July 8, 2024

Treatment Practices for Extended-Stage Small Cell Lung Cancer

Author(s)Rahul Gosain, MD, Rohit Gosain, MD, Eric Singhi, MD

Medical oncologists provide comprehensive insights on treatment practices for patients with extended-stage small cell lung cancer.

Episodes in this series

Eric Singhi, MD, and the Oncology Brothers presenting slides

EP. 1 Treatment Algorithm for Limited-Stage Small Cell Lung Cancer

Eric Singhi, MD, and the Oncology Brothers presenting slides

EP. 2 Incorporating PCI Following ADRIATIC Study

Eric Singhi, MD, and the Oncology Brothers presenting slides

EP. 3 Treatment Practices for Extended-Stage Small Cell Lung Cancer

Eric Singhi, MD, and the Oncology Brothers presenting slides

EP. 4 Adverse Event Management Practices in SCLC

Eric Singhi, MD, and the Oncology Brothers presenting slides

EP. 5 Treating Patients with SCLC with Driver Mutations

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Related to this article

3D Rendered Medical Illustration of Male Anatomy - Lung Cancer. | Image Credit: © Sebastian Kaulitzki - stock.adobe.com

October 27th, 2026

Novel SEZ6-Directed ADC Shows Robust Activity in Relapsed/Refractory SCLC

Biomarker and preclinical data support SEZ6 as a potential therapeutic target in small cell lung cancer management.

Trending on CancerNetwork

Setting Up an HDR Brachytherapy Program Amid a National Decline

Zamto-Cel Improves EFS vs R-GemOx in Transplant-Ineligible R/R LBCL

Biomarker Sequencing, PD-L1 Status, and FLOT Dosing in Gastroesophageal Cancer

CD38-Targeted Immuno-PET Helps Detect Active Multiple Myeloma

16-Fraction PMRT With IMN Irradiation Noninferior in High-Risk Breast Cancer